Report cover image

Asia Pacific Radiopharmaceuticals Market Growth, Size, Trends Analysis - By Product, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Jul 08, 2025
Length 255 Pages
SKU # SPER20314908

Description

Asia Pacific Radiopharmaceuticals Market Introduction and Overview

According to SPER market research, ‘Asia Pacific Radiopharmaceuticals Market Size- By Product, By Application, By End User – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Asia Pacific Radiopharmaceuticals Market is predicted to reach 5.89 billion by 2034 with a CAGR of 10.76%.

The radiopharmaceuticals market is the industry that creates, produces, and distributes radioactive compounds, which are primarily used to diagnose and cure diseases. These chemicals, known as radiopharmaceuticals, combine a radioactive isotope and a physiologically active molecule to target specific organs, tissues, or cells in the body. They are widely employed in nuclear medicine and play an important part in imaging techniques such as PET and SPECT scans, as well as targeted cancer treatments.

Restraints:Several constraints limit the growth of the Asia-Pacific radiopharmaceuticals market. Radiopharmaceuticals are expensive due to the high manufacturing costs associated with cyclotrons, reactors, and stringent quality controls. Regulatory complexity and stringent safety standards cause product approvals to be delayed and operational burdens to rise.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered Product, By Application, By End User

Regions covered

Japan, China, India, Singapore, Australia, South Korea, New Zealand, Thailand, Philippines

Companies Covered

Nordion Inc, Bracco, IRE - IRE ELiT - BE, NTP, ANSTO, ECZACIBAÅžI-MONROL, Lantheus, Eckert & Ziegler, Mallinckrodt company, Cardinal Health.

Asia Pacific Radiopharmaceuticals Market Segmentation:

By Product: Based on the Product, Asia Pacific Radiopharmaceuticals Market is segmented as; Diagnostics, Therapeutics.

By Application: Based on the Application, Asia Pacific Radiopharmaceuticals Market is segmented as; Cardiology, Neurology, Oncology, Thyroid, Lymphoma, Endocrine Tumor, Pulmonary Scans, Urology, Others.

By End User:
Based on the End User, Asia Pacific Radiopharmaceuticals Market is segmented as; Hospitals, Diagnostic Centres, Others.

By Region:
This research also includes data for Japan, China, India, Singapore, Australia, South Korea, New Zealand, Thailand, Philippines.

Table of Contents

255 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Asia Pacific Radiopharmaceuticals Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Asia Pacific Radiopharmaceuticals Market
7. Asia Pacific Radiopharmaceuticals Market, By Product (USD Million) 2021-2034
7.1. Diagnostics
7.2. Therapeutics
8. Asia Pacific Radiopharmaceuticals Market, By Application (USD Million) 2021-2034
8.1. Cardiology
8.2. Neurology
8.3. Oncology
8.4. Thyroid
8.5. Lymphoma
8.6. Endocrine Tumor
8.7. Pulmonary Scans
8.8. Urology
8.9. Others
9. Asia Pacific Radiopharmaceuticals Market, By End User (USD Million) 2021-2034
9.1. Hospitals
9.2. Diagnostic Centres
9.3. Others
10. Asia Pacific Radiopharmaceuticals Market, (USD Million) 2021-2034
10.1. Asia Pacific Radiopharmaceuticals Market Size and Market Share
11. Asia Pacific Radiopharmaceuticals Market, By Region, (USD Million) 2021-2034
11.1. Japan
11.2. China
11.3. India
11.4. Singapore
11.5. Australia
11.6. South Korea
11.7. New Zealand
11.8. Thailand
11.9. Philippines
12. Company Profile
12.1. ANSTO
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Bracco
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Cardinal Health
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Eckert & Ziegler
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. ECZACIBAÅžI-MONROL
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. IRE - IRE ELiT - BE
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Lantheus
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Mallinckrodt Company
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Nordion Inc
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. NTP
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us